Mizuho raises HCA price objective to $102: 5 quick notes

Mizuho analysts raised its price objective of Hospital Corporation of America stock to $102, according to EMQ News & Analysis.

Advertisement

Here are five quick notes:

1. The analysts’ target price indicates a potential upside of nearly 47 percent from HCA’s currents price.

2. HCA has a 12-month low of $43.91 and a 12-month high of $95.49.

3. The company has a 50-day moving average of $66.29.

4. The 200-day moving average is $76.58.

5. The market cap is $27.74 billion.

More articles on surgery centers:
Morningstar gives Tenet shares ‘B’ credit rating: 5 quick facts
8 things to know about HCA’s Q4 results
DPR Construction moves forward in building Shriners for Children Medical Center’s outpatient center, includes ASC: 4 highlights

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in ASC Transactions & Valuation Issues

Advertisement

Comments are closed.